With $92M, Kivu sets out to make ‘kinder, gentler’ ADCs
Bio Pharma Dive
OCTOBER 27, 2024
The startup claims its proprietary linker molecules can yield ADCs that are more precise and potent than existing options.
Bio Pharma Dive
OCTOBER 27, 2024
The startup claims its proprietary linker molecules can yield ADCs that are more precise and potent than existing options.
JAMA Internal Medicine
OCTOBER 27, 2024
This randomized clinical trial evaluates whether vitamin K2 is better than placebo in managing nocturnal leg cramps.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
FDA Law Blog
OCTOBER 27, 2024
By Deborah L. Livornese & John W.M. Claud & Charles D. Snow — On October 21, 2024, the Alliance for Natural Health USA (“ANH”), and Meditrend Inc., a homeopathic drug company, filed a complaint on behalf of the homeopathic drug industry against FDA in the District Court for the District of Columbia (“D.D.C.”). This lawsuit presents an interesting reading of the statute at issue, one that is diametrically opposed to that of FDA.
JAMA Internal Medicine
OCTOBER 27, 2024
To the Editor We read with interest the article by Advani et al on recurrent urinary tract infections (UTIs) in older women and would like to contribute to the discussion on the prevention of future UTI episodes in this population. Specifically, we would like to address the authors’ suggestion of consulting a physician before consuming cranberries because they have not been proven to reduce the incidence of infections.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Patent Watch
OCTOBER 27, 2024
A troubling trend has emerged in recent years, leaving both healthcare providers and patients grappling with an unexpected challenge: the persistent shortage of generic drugs in hospitals. This issue has far-reaching consequences, affecting patient care, hospital operations, and the broader healthcare system.
Let's personalize your content